IM To establish a nonradioactive assay for 2′5′ oligoadenylate synthetase (25 AS) and to measure the 25AS in peripheral blood mononuclear cell (PBMC) extracts of patients with chronic hepatitis C before IFNα injec...IM To establish a nonradioactive assay for 2′5′ oligoadenylate synthetase (25 AS) and to measure the 25AS in peripheral blood mononuclear cell (PBMC) extracts of patients with chronic hepatitis C before IFNα injection, 24 hours and one month after the first injection.METHODS 25AS in cell extracts of PBMCs from 10 normal persons and 15 chronic hepatitis C patients were determined with PEI cellulose thinlayer chromatography.RESULTS The assay of 25AS in human PBMC was found to be rapid, sensitive, specific and reliable. The 25AS activity of PBMC in normal persons was in a quite low level (20%), and it was increased about tenfolds after stimulation of IFN (197%), (P<001). In 15 chronic hepatitic C patients, the basal levels of 25AS before IFN treatment were higher than those of normal persons, being much higher in the group showing poor response to IFN treatment, but 24h after the first injection of IFNα the 25AS level showed a more rapid and much greater rise in those patients with a good response.CONCLUSION 25AS may be a useful parameter of biological response during the IFN therapy..展开更多
文摘IM To establish a nonradioactive assay for 2′5′ oligoadenylate synthetase (25 AS) and to measure the 25AS in peripheral blood mononuclear cell (PBMC) extracts of patients with chronic hepatitis C before IFNα injection, 24 hours and one month after the first injection.METHODS 25AS in cell extracts of PBMCs from 10 normal persons and 15 chronic hepatitis C patients were determined with PEI cellulose thinlayer chromatography.RESULTS The assay of 25AS in human PBMC was found to be rapid, sensitive, specific and reliable. The 25AS activity of PBMC in normal persons was in a quite low level (20%), and it was increased about tenfolds after stimulation of IFN (197%), (P<001). In 15 chronic hepatitic C patients, the basal levels of 25AS before IFN treatment were higher than those of normal persons, being much higher in the group showing poor response to IFN treatment, but 24h after the first injection of IFNα the 25AS level showed a more rapid and much greater rise in those patients with a good response.CONCLUSION 25AS may be a useful parameter of biological response during the IFN therapy..